Career & Filing History
Every role Diana McKenzie has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Diana McKenzie holds the role of Director at METLIFE INC (MET). McKenzie's filing history also covers agilon health, inc. (AGL) and VERTEX PHARMACEUTICALS INC / MA (VRTX). McKenzie has reported 14 insider filings with the SEC since 2024. The most recent filing was in June 2026.
Every role Diana McKenzie has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
METLIFE INC (MET)2 filingsagilon health, inc. (AGL)1 filingUpdated Aug 30, 2026
Diana McKenzie is Director of METLIFE INC (MET). 14 SEC Form 4 filings on record going back to 2024, most recently on 18 June 2026. Most recent open-market trade: bought $16K of AGL on 11 December 2024. Lifetime open-market purchases: $45K.
Every recent SEC Form 4 transaction Diana McKenzie has reported, most recent first.
InsiderAlpha's records for Diana McKenzie go back to 2024: 14 primary Form 4 filings, an average of 4.7 per year. The typical open-market purchase is $22K (2 buys totaling $45K). The largest single buy on record is $28K of AGL in 2024. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Insiders who reported open-market trades in the last 12 months at the companies Diana McKenzie files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Diana McKenzie is a corporate insider, tracked as Director of METLIFE INC (MET). InsiderAlpha holds 14 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 2 open-market purchases ($45K) and 0 open-market sales across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
$AGL agilon health, inc.2.1K shares @ $0.00-